SCHEMBL7303976

SCHEMBL7303976

[O]c1cccc2c(Br)c(Br)ccc12

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.31
GABRA1 P14867 1/20 0.30
GABRB2 P47870 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8900857 0.78 PARP1 (0.43) PARP1
SCHEMBL7692011 0.78 PARP1 (0.48) PARP1
SCHEMBL7689606 0.73 RXFP1 (0.44) PARP1
SCHEMBL8726015 0.73
SCHEMBL8726013 0.73
SCHEMBL1043235 0.72
SCHEMBL14353675 0.70 ALDH1A1 (0.48) PARP1
SCHEMBL5254656 0.68 GABRA1 (0.35) GABRA1GABRB2
SCHEMBL2548078 0.68 HPRT1 (0.64)
SCHEMBL603488 0.68 HPRT1 (0.64)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5629406-A AMINO ACID DERIVATIVES SANKYO COMPANY, LIMITED (JP) 1997-05-13 US disclosed
EP-0587311-A1 Peptides capable of inhibiting the activity of HIV protease, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1994-03-16 EP disclosed